PRO: Should Patients Taking Sodium-Glucose Co-Transporter 2 Inhibitors Be Dropped From the Elective Surgical Program?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PRO: Should Patients Taking Sodium-Glucose Co-Transporter 2 Inhibitors Be Dropped From the Elective Surgical Program?

Published:2024-07 Issue:7 Volume:38 Page:1587-1589
ISSN:1053-0770
Container-title:Journal of Cardiothoracic and Vascular Anesthesia
language:en
Short-container-title:Journal of Cardiothoracic and Vascular Anesthesia

Author:

Ryz Sylvia^ORCID,Castellucci Clara

Publisher

Elsevier BV

Reference13 articles.

1. Starr JA, Pinner NA. The impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with preserved ejection fraction [e-pub ahead of print]. Ann Pharmacother. doi:10.1177/10600280231189508. Accessed August 05, 2023.

2. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;Perkovic;New Engl J Med,2019

3. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: Cardiovascular and kidney effects, potential mechanisms, and clinical applications;Heerspink;Circulation,2016

4. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis;Handelsman;Endocr Pract,2016

5. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: A systematic review;Thiruvenkatarajan;Brit J Anaesthes,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3